期刊
PATHOLOGY RESEARCH AND PRACTICE
卷 231, 期 -, 页码 -出版社
ELSEVIER GMBH
DOI: 10.1016/j.prp.2022.153800
关键词
PCA3; LncRNA; Prostate cancer; Diagnostic marker; EMT
类别
PCA3 is a lncRNA with high specificity for prostate cancer and plays a crucial role in the pathogenesis of prostate cancer. It regulates multiple signaling pathways and is also expressed in other types of cancer cells. Several studies have evaluated the diagnostic value of PCA3 in prostate cancer and found that it has moderate diagnostic ability.
The prostate cancer antigen 3 (PCA3) is a long non-coding RNA (lncRNA) with high level of specificity for prostate cancer. This lncRNA has fundamental effects in the prostate carcinogenesis through modulation of expression of miR-132-3p, miR-1261, SREBP1, PRKD3 and LAP2 alpha as well as regulation of p53 signaling. Expression of PCA3 in prostate cancer cells can be enhanced by Snail. Moreover, in vitro studies have documented up-regulation of PCA3 in three other types of neoplastic cells, namely those being originated from choriocarcinoma, ovarian carcinoma and thyroid carcinoma. The diagnostic value of PCA3 in differentiation of prostate cancer from benign prostate hyperplasia has been assessed in different studies. Studies aimed at identification of diagnostic power of PCA3 in prostate cancer using receiver operating characteristic curves have reported area under curve values ranging from 0.66 to 0.86. In the current review, we describe the role of PCA3 in the carcinogenesis particularly in the pathoetiology of prostate cancer. Moreover, we review the results of studies appraising diagnostic value of this lncRNA in prostate cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据